P10 Antiphospholipid antibodies associated extra-criteria clinical manifestations should not be ignored. (23rd March 2020)
- Record Type:
- Journal Article
- Title:
- P10 Antiphospholipid antibodies associated extra-criteria clinical manifestations should not be ignored. (23rd March 2020)
- Main Title:
- P10 Antiphospholipid antibodies associated extra-criteria clinical manifestations should not be ignored
- Authors:
- Zhao, Jiuliang
Hu, Chaojun
Huang, Can
Tian, Xinping
Li, Mengtao
Zeng, Xiaofeng - Abstract:
- Abstract : Background: The current Sydney classification criteria do not consider a range of non-thrombotic clinical manifestations that are frequently observed in association with the presence of aPLs, the so-called extra-criteria manifestations. The aim of this study was to retrospectively analysis our single center Antiphospholipid antibodies associated clinical phenotypes, especially the frequency of extra-criteria manifestations. Methods: Data of 731 serum samples from patients of clinical suspected APS in 2018 were enrolled. Data of clinical features, laboratory examination, treatment and prognosis were retrospectively analyzed. Results: A total of 200 patients with APLs were positive (27%), 56 males and 144 females, with an average age of 40.13±17.24 years, 115 cases (57.5%) with ACL positive, 167 cases (83.5%) with anti-β2GPI antibodies positive, 69 cases (34.5%) with LA positive, and 20 cases (10%) turned negative after 12 weeks without any specific therapy. 61(30.5%) patients were fulfilled the 2006 revised Sydney classification criteria for APS. One patient was Catastrophic APS. 27(44.3%) patients with primary APS, 34 (55.6%) were secondary APS, including SLE-APS (20), CTD (9), infection (3), malignancies (2). 119 patients with persistent APLs positive, but were not fulfilled the APS criteria because of without thrombosis or fetal loss. 77 (42.8%) patients were asymptomatic, 42 patients with extra-criteria manifestations. The total frequency of extra-criteriaAbstract : Background: The current Sydney classification criteria do not consider a range of non-thrombotic clinical manifestations that are frequently observed in association with the presence of aPLs, the so-called extra-criteria manifestations. The aim of this study was to retrospectively analysis our single center Antiphospholipid antibodies associated clinical phenotypes, especially the frequency of extra-criteria manifestations. Methods: Data of 731 serum samples from patients of clinical suspected APS in 2018 were enrolled. Data of clinical features, laboratory examination, treatment and prognosis were retrospectively analyzed. Results: A total of 200 patients with APLs were positive (27%), 56 males and 144 females, with an average age of 40.13±17.24 years, 115 cases (57.5%) with ACL positive, 167 cases (83.5%) with anti-β2GPI antibodies positive, 69 cases (34.5%) with LA positive, and 20 cases (10%) turned negative after 12 weeks without any specific therapy. 61(30.5%) patients were fulfilled the 2006 revised Sydney classification criteria for APS. One patient was Catastrophic APS. 27(44.3%) patients with primary APS, 34 (55.6%) were secondary APS, including SLE-APS (20), CTD (9), infection (3), malignancies (2). 119 patients with persistent APLs positive, but were not fulfilled the APS criteria because of without thrombosis or fetal loss. 77 (42.8%) patients were asymptomatic, 42 patients with extra-criteria manifestations. The total frequency of extra-criteria manifestations associated with APLs are 40%. The details are shown in table 1 . Conclusions: The most common extra-criteria manifestations are thrombocytopenia, non-vascular neurological manifestations and valvular heart disease. And they can be the independent clinical feature of APLs without thrombotic events or Pregnancy morbidities. … (more)
- Is Part Of:
- Lupus science & medicine. Volume 7(2020)Supplement 1
- Journal:
- Lupus science & medicine
- Issue:
- Volume 7(2020)Supplement 1
- Issue Display:
- Volume 7, Issue 1 (2020)
- Year:
- 2020
- Volume:
- 7
- Issue:
- 1
- Issue Sort Value:
- 2020-0007-0001-0000
- Page Start:
- A33
- Page End:
- A34
- Publication Date:
- 2020-03-23
- Subjects:
- Systemic lupus erythematosus -- Periodicals
616.772005 - Journal URLs:
- http://www.bmj.com/archive ↗
http://lupus.bmj.com/ ↗ - DOI:
- 10.1136/lupus-2020-eurolupus.59 ↗
- Languages:
- English
- ISSNs:
- 2398-8851
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19741.xml